Bio-Techne (TECH): are the analysts right?

Bio-Techne · Health Care · ref. ETF XLV · 50 calls · price $70.61
What the company does: Bio-Techne développe et vend réactifs science de la vie, instruments et services diagnostiques.
📈 1-year price
$70.61+34.0% over range
Jul 8, 25low $43.3 · high $71.38Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
18% recommend buying · 11 analysts

🎯 Analyst price target on TECH

High target · 1 analyst$79+11.9%
Median target · 9 analysts$73+3.4%
Low target · 1 analyst$50-29.2%
Current price$70.61

🗳️ The analyst consensus

Analyst breakdown · 11 (6 months)
Strong Buy0%
Buy18%
Hold82%
Sell0%
Strong Sell0%

💰 Bio-Techne dividend

0.45%annual yield
That's ~$0.32 per share per year.

✅ Historical analyst reliability on TECH

Most reliable analysts on TECH (% profitable · 365j · ≥2 calls)
Benchmark 25% -14.7% 4
Scotiabank 0% -14.4% 2
Baird 0% -19.1% 3

📊 What $1,000 invested in Bio-Techne would be worth

In short — $1,000 invested in Bio-Techne 10 years ago would be worth $3,140 today, i.e. +12%/yr on average. Best year: 2021 (+63%), worst: 2022 (-36%). Price performance, excluding dividends.

If I'd invested $1,000 in Bio-Techne

InvestmentWorth todayGain
1 years ago$981-2%
3 years ago$852-15%
5 years ago$890-11%
10 years ago$3,140+214%
since inception (1989)$695,374+69437%

Return by year (Bio-Techne)

YearReturn$1,000 invested at year start
2026 (YTD)+20%$1,201 (+20%)
2025-18%$981 (-2%)
2024-7%$916 (-8%)
2023-7%$852 (-15%)
2022-36%$546 (-45%)
2021+63%$890 (-11%)
2020+45%$1,287 (+29%)
2019+52%$1,953 (+95%)
2018+12%$2,181 (+118%)
2017+26%$2,748 (+175%)
2016+14%$3,140 (+214%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance💰 Dividend
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on TECH

TD Cowen
Jun 30, 26
■ Hold neutral · not a buy · 🎯$73
Price at call : $71 — gap to target +3%
Today : $70.61 — gap to target +3%
🎯 on TECH : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Jun 30, 27
Benchmark
Jun 30, 26
■ Hold neutral · not a buy
🎯 on TECH : 25% (4 calls matureds) · 📊 on Health : 47.4% · -1.5% (19 calls)
in progress (365j)
matures : Jun 30, 27
Citigroup
Jun 29, 26
■ Neutral neutral · not a buy · 🎯$73
Price at call : $70.9 — gap to target +3%
Today : $70.61 — gap to target +3%
🎯 on TECH : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Jun 29, 27
■ Equal-Weight neutral · not a buy · 🎯$73
Price at call : $70.9 — gap to target +3%
Today : $70.61 — gap to target +3%
🎯 on TECH : no call matured yet · 📊 on Health : 52.5% · +0.2% (99 calls)
in progress (365j)
matures : Jun 26, 27
William Blair
Jun 26, 26
■ Market Perform neutral · not a buy
🎯 on TECH : no call matured yet · 📊 on Health : 65.4% · +5.6% (26 calls)
in progress (365j)
matures : Jun 26, 27
Baird
Jun 26, 26
■ Neutral neutral · not a buy · 🎯$73
Price at call : $71 — gap to target +3%
Today : $70.61 — gap to target +3%
🎯 on TECH : 0% (3 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Jun 26, 27
Piper Sandler
Jun 11, 26
■ Neutral neutral · not a buy · 🎯$65
Price at call : $54.02 — gap to target +20%
Today : $70.61 — gap to target -8%
🎯 on TECH : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Jun 11, 27
Citigroup
May 7, 26
▲ Buy · 🎯$70
Price at call : $48.36 — upside +45%
Today : $70.61 — upside -1%
🎯 on TECH : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : May 7, 27
Wells Fargo
May 7, 26
▲ Overweight · 🎯$62
Price at call : $48.36 — upside +28%
Today : $70.61 — upside -12%
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : May 7, 27
■ In-Line neutral · not a buy · 🎯$50
Price at call : $48.36 — gap to target +3%
Today : $70.61 — gap to target -29%
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : May 7, 27
■ In-Line neutral · not a buy · 🎯$54
Price at call : $53.83 — gap to target +0%
Today : $70.61 — gap to target -24%
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Apr 6, 27
Wells Fargo
Feb 6, 26
▲ Overweight · 🎯$76
Price at call : $65.48 — upside +16%
Today : $70.61 — upside +8%
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Feb 6, 27
Citigroup
Feb 5, 26
▲ Buy · 🎯$80
Price at call : $66.78 — upside +20%
Today : $70.61 — upside +13%
🎯 on TECH : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Feb 5, 27
Stifel
Feb 5, 26
■ Hold neutral · not a buy · 🎯$65
Price at call : $66.78 — gap to target -3%
Today : $70.61 — gap to target -8%
🎯 on TECH : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Feb 5, 27
TD Cowen
Feb 5, 26
▲ Buy · 🎯$80
Price at call : $66.78 — upside +20%
Today : $70.61 — upside +13%
🎯 on TECH : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Feb 5, 27
UBS
Feb 5, 26
▲ Buy · 🎯$79
Price at call : $66.78 — upside +18%
Today : $70.61 — upside +12%
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Feb 5, 27
■ In-Line neutral · not a buy · 🎯$68
Price at call : $66.78 — gap to target +2%
Today : $70.61 — gap to target -4%
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Feb 5, 27
■ In-Line neutral · not a buy · 🎯$62
Price at call : $65.28 — gap to target -5%
Today : $70.61 — gap to target -12%
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Jan 5, 27
▲ Buy · 🎯$68
Price at call : $58.73 — upside +16%
Today : $70.61 — upside -4%
🎯 on TECH : no call matured yet · 📊 on Health : 56.4% · +2.9% (156 calls)
in progress (365j)
matures : Nov 20, 26
UBS
Nov 6, 25
▲ Buy · 🎯$70
Price at call : $57.41 — upside +22%
Today : $70.61 — upside -1%
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Nov 6, 26
Wells Fargo
Nov 6, 25
▲ Overweight · 🎯$70
Price at call : $57.41 — upside +22%
Today : $70.61 — upside -1%
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Nov 6, 26
TD Cowen
Oct 14, 25
▲ Buy · 🎯$70
Price at call : $59.27 — upside +18%
Today : $70.61 — upside -1%
🎯 on TECH : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Oct 14, 26
▲ Outperform · 🎯$72
Price at call : $60.56 — upside +19%
Today : $70.61 — upside +2%
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Oct 7, 26
RBC Capital
Sep 3, 25
▲ Outperform · 🎯$73
Price at call : $52.92 — upside +38%
Today : $70.61 — upside +3%
🎯 on TECH : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Sep 3, 26
Citigroup
Aug 21, 25
▲ Buy · 🎯$70
Price at call : $54 — upside +30%
Today : $70.61 — upside -1%
🎯 on TECH : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Aug 21, 26
RBC Capital
Aug 7, 25
■ Sector Perform neutral · not a buy · 🎯$61
Price at call : $50.42 — gap to target +21%
Today : $70.61 — gap to target -14%
🎯 on TECH : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Aug 7, 26
Scotiabank
Jul 11, 25
▲ Sector Outperform · 🎯$75
Price at call : $52.62 — upside +43%
Today : $70.61 — upside +6%
🎯 on TECH : 0% (2 calls matureds) · 📊 on Health : 16.7% · -12.6% (6 calls)
in progress (365j)
matures : Jul 11, 26
TD Cowen
Jul 9, 25
▲ Buy · 🎯$65
Price at call : $52.59 — upside +24%
Today : $70.61 — upside -8%
🎯 on TECH : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Jul 9, 26
Benchmark
Jun 5, 25
▲ Buy · 🎯$75
Price at call : $48.69 — upside +54%
Today : $70.61 — upside +6%
Expected +54% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 25% (4 calls matureds) · 📊 on Health : 47.4% · -1.5% (19 calls)
+8.1%
stock +8% · XLV +14%
Wells Fargo
May 30, 25
▲ Overweight · 🎯$59
Price at call : $48.4 — upside +22%
Today : $70.61 — upside -16%
Expected +22% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 49.3% · +2.1% (371 calls)
+4.9%
stock +5% · XLV +11%
UBS
May 10, 25
▲ Buy · 🎯$70
Price at call : $53.9 — upside +30%
Today : $70.61 — upside -1%
Expected +30% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
-12.0%
stock -12% · XLV +5%
RBC Capital
May 8, 25
■ Sector Perform neutral · not a buy · 🎯$63
Price at call : $49.94 — gap to target +26%
Today : $70.61 — gap to target -11%
🎯 on TECH : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : May 8, 26
Benchmark
May 8, 25
▲ Buy · 🎯$75
Price at call : $49.94 — upside +50%
Today : $70.61 — upside +6%
Expected +50% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 25% (4 calls matureds) · 📊 on Health : 47.4% · -1.5% (19 calls)
-5.1%
stock -5% · XLV +8%
Stifel
May 8, 25
■ Hold neutral · not a buy · 🎯$60
Price at call : $49.94 — gap to target +20%
Today : $70.61 — gap to target -15%
🎯 on TECH : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : May 8, 26
Keybanc
Apr 9, 25
■ Sector Weight neutral · not a buy
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 44.6% · -1.1% (139 calls)
in progress (365j)
matures : Apr 9, 26
Keybanc
Apr 8, 25
■ Sector Weight neutral · not a buy
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 44.6% · -1.1% (139 calls)
in progress (365j)
matures : Apr 8, 26
▲ Outperform · 🎯$75
Price at call : $62.83 — upside +19%
Today : $70.61 — upside +6%
Expected +19% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 47.6% · +1.3% (147 calls)
-19.1%
stock -19% · XLV +0%
Citigroup
Mar 4, 25
■ Neutral neutral · not a buy · 🎯$70
Price at call : $62.2 — gap to target +13%
Today : $70.61 — gap to target -1%
🎯 on TECH : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Mar 4, 26
Baird
Feb 19, 25
■ Neutral neutral · not a buy · 🎯$68
Price at call : $65.8 — gap to target +3%
Today : $70.61 — gap to target -4%
🎯 on TECH : 0% (3 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Feb 19, 26
RBC Capital
Feb 6, 25
■ Sector Perform neutral · not a buy · 🎯$80
Price at call : $72.81 — gap to target +10%
Today : $70.61 — gap to target +13%
🎯 on TECH : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Feb 6, 26
Scotiabank
Feb 6, 25
▲ Sector Outperform · 🎯$90
Price at call : $72.81 — upside +24%
Today : $70.61 — upside +27%
Expected +24% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 0% (2 calls matureds) · 📊 on Health : 16.7% · -12.6% (6 calls)
-10.1%
stock -10% · XLV +7%
Keybanc
Feb 6, 25
▲ Overweight · 🎯$90
Price at call : $72.81 — upside +24%
Today : $70.61 — upside +27%
Expected +24% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 44.6% · -1.1% (139 calls)
-10.1%
stock -10% · XLV +7%
Baird
Feb 6, 25
▲ Outperform · 🎯$88
Price at call : $75.01 — upside +17%
Today : $70.61 — upside +25%
Expected +17% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 0% (3 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
-11.0%
stock -11% · XLV +7%
Scotiabank
Oct 31, 24
▲ Sector Outperform · 🎯$88
Price at call : $75.31 — upside +17%
Today : $70.61 — upside +25%
Expected +17% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 0% (2 calls matureds) · 📊 on Health : 16.7% · -12.6% (6 calls)
-18.7%
stock -19% · XLV -2%
Baird
Oct 31, 24
▲ Outperform · 🎯$84
Price at call : $73.75 — upside +14%
Today : $70.61 — upside +19%
Expected +14% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 0% (3 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
-15.2%
stock -15% · XLV -2%
Benchmark
Aug 13, 24
▲ Buy · 🎯$95
Price at call : $72.75 — upside +31%
Today : $70.61 — upside +35%
Expected +31% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 25% (4 calls matureds) · 📊 on Health : 47.4% · -1.5% (19 calls)
-26.1%
stock -26% · XLV -12%
RBC Capital
Aug 8, 24
■ Sector Perform neutral · not a buy · 🎯$70
Price at call : $71.77 — gap to target -2%
Today : $70.61 — gap to target -1%
🎯 on TECH : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Aug 8, 25
Baird
Aug 8, 24
▲ Outperform · 🎯$82
Price at call : $73.37 — upside +12%
Today : $70.61 — upside +16%
Expected +12% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 0% (3 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
-31.3%
stock -31% · XLV -13%
Citigroup
May 22, 24
■ Neutral neutral · not a buy · 🎯$85
Price at call : $82.98 — gap to target +2%
Today : $70.61 — gap to target +20%
🎯 on TECH : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : May 22, 25
Benchmark
May 2, 24
▲ Buy · 🎯$95
Price at call : $77.29 — upside +23%
Today : $70.61 — upside +35%
Expected +23% · Actual -36% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 25% (4 calls matureds) · 📊 on Health : 47.4% · -1.5% (19 calls)
-35.6%
stock -36% · XLV -2%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)